Nature Communications (Aug 2023)

DNA methylation at the suppressor of cytokine signaling 3 (SOCS3) gene influences height in childhood

  • Prachand Issarapu,
  • Manisha Arumalla,
  • Hannah R. Elliott,
  • Suraj S. Nongmaithem,
  • Alagu Sankareswaran,
  • Modupeh Betts,
  • Sara Sajjadi,
  • Noah J. Kessler,
  • Swati Bayyana,
  • Sohail R. Mansuri,
  • Maria Derakhshan,
  • G. V. Krishnaveni,
  • Smeeta Shrestha,
  • Kalyanaraman Kumaran,
  • Chiara Di Gravio,
  • Sirazul A. Sahariah,
  • Eleanor Sanderson,
  • Caroline L. Relton,
  • Kate A. Ward,
  • Sophie E. Moore,
  • Andrew M. Prentice,
  • Karen A. Lillycrop,
  • Caroline H. D. Fall,
  • Matt J. Silver,
  • Giriraj R. Chandak,
  • the EMPHASIS study group

DOI
https://doi.org/10.1038/s41467-023-40607-0
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 16

Abstract

Read online

Abstract Human height is strongly influenced by genetics but the contribution of modifiable epigenetic factors is under-explored, particularly in low and middle-income countries (LMIC). We investigate links between blood DNA methylation and child height in four LMIC cohorts (n = 1927) and identify a robust association at three CpGs in the suppressor of cytokine signaling 3 (SOCS3) gene which replicates in a high-income country cohort (n = 879). SOCS3 methylation (SOCS3m)—height associations are independent of genetic effects. Mendelian randomization analysis confirms a causal effect of SOCS3m on height. In longitudinal analysis, SOCS3m explains a maximum 9.5% of height variance in mid-childhood while the variance explained by height polygenic risk score increases from birth to 21 years. Children’s SOCS3m is associated with prenatal maternal folate and socio-economic status. In-vitro characterization confirms a regulatory effect of SOCS3m on gene expression. Our findings suggest epigenetic modifications may play an important role in driving child height in LMIC.